These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7378190)

  • 21. Antagonizing potencies of saturated and unsaturated long-chain free fatty acids to isoflurane in goldfish.
    Hanada R; Tatara T; Iwao Y
    J Anesth; 2004; 18(2):89-93. PubMed ID: 15127255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombin receptor-activating peptide releases arachidonic acid from human platelets: a comparison with thrombin and trypsin.
    McNicol A; Robson CA
    J Pharmacol Exp Ther; 1997 May; 281(2):861-7. PubMed ID: 9152395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
    Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
    Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of heparin and hirudin on thrombin generation and platelet aggregation after intrinsic activation of platelet rich plasma.
    Gallistl S; Muntean W; Leis HJ
    Thromb Haemost; 1995 Oct; 74(4):1163-8. PubMed ID: 8560429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of physiologic shear stresses and calcium on agonist-induced platelet aggregation, secretion, and thromboxane A2 formation.
    Viisoreanu D; Gear A
    Thromb Res; 2007; 120(6):885-92. PubMed ID: 17306868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of platelet function by cis-unsaturated fatty acids.
    MacIntyre DE; Hoover RL; Smith M; Steer M; Lynch C; Karnovsky MJ; Salzman EW
    Blood; 1984 Apr; 63(4):848-57. PubMed ID: 6322886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of thrombin-neutralizing activity of antithrombin III by steroid hormones.
    Nagasawa H; Kim BK; Steiner M; Baldini MG
    Thromb Haemost; 1982 Apr; 47(2):157-61. PubMed ID: 7101236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytoskeletal changes in platelets induced by thrombin and phorbol myristate acetate (PMA).
    Chen R; Liang N
    Cell Biol Int; 1998; 22(6):429-35. PubMed ID: 10328851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of rat platelet aggregation by mycalolide-B, a novel inhibitor of actin polymerization with a different mechanism of action from cytochalasin-D.
    Sugidachi A; Ogawa T; Asai F; Saito S; Ozaki H; Fusetani N; Karaki H; Koike H
    Thromb Haemost; 1998 Mar; 79(3):614-9. PubMed ID: 9531051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of methylglyoxal on platelet hydrogen peroxide accumulation, aggregation and release reaction.
    Leoncini G; Poggi M
    Cell Biochem Funct; 1996 Jun; 14(2):89-95. PubMed ID: 8640957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ADP-dependence of platelet activation induced by a thrombin receptor agonist.
    Savi P; Dol F; Herbert JM
    Nouv Rev Fr Hematol (1978); 1993 Apr; 35(2):115-9. PubMed ID: 8392699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ristocetin- and thrombin-induced platelet aggregation at physiological shear rates: differential roles for GPIb and GPIIb-IIIa receptor.
    Kasirer-Friede A; Frojmovic MM
    Thromb Haemost; 1998 Sep; 80(3):428-36. PubMed ID: 9759623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proceedings: Ultrastructural changes in human platelet during fatty acid salt aggregation.
    Prost-Dvojakovic RJ; Le Men R; Soria J; Boisseau M
    Thromb Diath Haemorrh; 1975 Nov; 34(2):567-8. PubMed ID: 1198450
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of nonesterified fatty acids on the stability of prostacyclin activity.
    Mikhailidis DP; Mikhailidis AM; Barradas MA; Dandona P
    Metabolism; 1983 Jul; 32(7):717-21. PubMed ID: 6345992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An endogenous inhibitor of PAF-induced platelet aggregation, isolated from rat liver, has been identified as free fatty acid.
    Siafaka-Kapadai A; Hanahan D
    Biochim Biophys Acta; 1993 Feb; 1166(2-3):217-21. PubMed ID: 8382959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Free fatty acid-induced platelet aggregation: studies with solubilized and nonsolubilized fatty acids.
    Zentner GM; Cardinal JR; Kim SW
    J Pharm Sci; 1981 Sep; 70(9):975-81. PubMed ID: 6101166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potentiating effect of 5,8,11-eicosatrienoic acid on human platelet aggregation.
    Lagarde M; Burtin M; Sprecher H; Dechavanne M; Renaud S
    Lipids; 1983 Apr; 18(4):291-4. PubMed ID: 6408333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of albumin-bound unsaturated fatty acids on platelets.
    Refsum N; Lowery C; Nordøy A
    Haemostasis; 1981; 10(1):3-13. PubMed ID: 7203174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of acute-phase synthesis of fibrinogen by a hypolipidemic drug (clofibrate).
    Pickart L
    Int J Tissue React; 1981 Jun; 3(2):65-72. PubMed ID: 7327616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.